GVGeorge Vorgias

George Vorgias

*This is an algorithmically generated author record based on publicly available information.

George Vorgias has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fallopian Tube Cytology for Exploratory Detection of Adnexal Malignancy: Prospective Evaluation of the CytoSaLPs Score in an Ex Vivo Surgical Cohort

    by Victoria Psomiadou, Sofia Lekka, Theodoros Panoskaltsis, Abraham Pouliakis, Eleni Tsouma, Natasa Novkovic, Helen J. Trihia, Olympia Tzaida, Dimitrios Korfias, Panagiotis Giannakas, et al.

    Objective: Ovarian, fallopian tube, and primary peritoneal cancers remain among the deadliest gynecological malignancies, largely because most cases are diagnosed at an advanced stage and no effective screening strategy is currently available. Increasing evidence suggests that many high-grade serous ovarian carcinomas originate from the fallopian tube. We aimed to explore the diagnostic performance of ex vivo fallopian tube cytology and the CytoSaLPs score for detecting tubal and adnexal malignancies in women undergoing salpingectomy or salpingo-oophorectomy. Methods: We conducted a prospective single-center observational study including 304 women undergoing salpingectomy or salpingo-oophorectomy for benign, premalignant or malignant gynecological indications between 2020 and 2023. Ex vivo cytological brushing of the distal fallopian tube was performed before fixation, followed by histopathological examination using the SEE-FIM protocol where appropriate. The primary analysis was performed at the specimen level. Of 544 paired specimens initially available for cytology–histology correlation, 53 non-diagnostic cytological specimens were excluded from the primary diagnostic performance analysis, leaving 491 evaluable paired specimens. Fallopian tube cytological findings were compared with histopathology as the reference standard. The discriminatory ability of the CytoSaLPs score was explored using receiver operating characteristic analysis. Results: Fallopian tube cytology demonstrated high sensitivity for histologically confirmed tubal malignancy, although specificity was moderate. Based on the primary specimen-level analysis, sensitivity was 94.4% and specificity was 71.0%. When fallopian tube cytology was compared with ovarian histology, sensitivity was 72.9% and specificity was 72.4%. For the adnexa considered as a single anatomical entity, sensitivity was 76.5% and specificity was 70.7%. The CytoSaLPs score showed good discriminatory ability for fallopian tube malignancy (AUC 0.8534), moderate discrimination for ovarian malignancy (AUC 0.6790), and fair discrimination for adnexal malignancy (AUC 0.730). The optimal score thresholds were derived from the same dataset and should therefore be considered provisional. Three serous tubal intraepithelial carcinoma lesions were identified histologically; two showed cytological abnormalities and elevated CytoSaLPs scores, whereas one specimen was non-diagnostic. Conclusions: This exploratory proof-of-concept study suggests that ex vivo fallopian tube and the CytoSaLPs score may provide a structured approach for detecting cytological abnormalities associated with tubal and adnexal malignancy. However, the findings were obtained in a tertiary gynecologic oncology population under ex vivo conditions, non-diagnostic specimens occurred in approximately 10% of samples, and the scoring system was developed and evaluated within the same cohort. Independent external validation and evaluation using clinically applicable in vivo sampling methods are required before any clinical implementation can be considered.

  • Open Access

    Fallopian Tube Cytology for Exploratory Detection of Adnexal Malignancy: Prospective Evaluation of the CytoSaLPs Score in an Ex Vivo Surgical Cohort

    by Victoria Psomiadou, Sofia Lekka, Theodoros Panoskaltsis, Abraham Pouliakis, Helen Tsouma, Natasa Novkovic, Helen J Trihia, Olympia Tzaida, Dimitrios Korfias, Panagiotis Giannakas, et al.

    Objective: Ovarian, fallopian tube, and primary peritoneal cancers are the deadliest gynecological malignancies, largely due to delayed diagnosis, tumor heterogeneity, and lack of effective methods for early detection. Increasing evidence suggests that most high-grade serous ovarian carcinomas originate from the fallopian tube epithelium. Consequently, recent studies have focused on fallopian tube cytology and its correlation with histological findings. We aimed to evaluate the exploratory diagnostic performance of ex vivo fallopian tube cytology and the CytoSaLPs score for detecting adnexal malignancies in women undergoing salpingectomy. Methods: We conducted a prospective observational study including 304 women undergoing salpingectomy or salpingo-oophorectomy for benign or malignant gynecological indications between 2020 and 2023. Ex vivo cytological brushing of the fimbrial end was performed before fixation. The primary endpoint was diagnostic accuracy compared with histology. Secondary endpoints included evaluation of the CytoSaLPs score using receiver operating characteristic analysis. Results: 491 speciments were obtained. Cytological findings were correlated with histology, demonstrating the diagnostic value of tubal cytology. For fallopian tubes, cytology showed a sensitivity of 94.4%, specificity of 71.0%. and accuracy of 72.7%. Ovarian cytology showed lower sensitivity (72.9%) and specificity (70.7%). For the adnexa as a single entity, sensitivity was 76.5% and specificity 70.7%. ROC analysis demonstrated strong performance of the CytoSaLPs Score for fallopian tubes (AUC 82.9%), moderate performance for ovaries (AUC 63.4%), and fair performance for adnexa overall (AUC 69.9%). Conclusion: This exploratory proof-of-concept study suggests that ex vivo fallopian tube cytology combined with the CytoSaLPs score may represent a promising adjunctive approach for future early detection strategies. External validation is required before clinical implementation.

  • Open Access

    Vaginal Evisceration After Abdominal Hysterectomy: A Case Report

    by Sofia Tsakona, Christos Iavazzo, Alexandros Fotiou, Kalliopi Kokkali, George Vorgias

    Vaginal cuff dehiscence (VCD) is an extremely rare complication after a hysterectomy, with possible life-threatening consequences. Multiple cases of pelvic organ evisceration through the vaginal cuff have been reported, most frequently precipitated by sexual intercourse. Surgeons should be suspicious of clinical signs of VCD postoperatively, as any intervention should be prompt. Patients at high-risk patients of developing vaginal cuff dehiscence should be advised to refrain from straining exercises for longer periods of time. Herein, we present the case of a 46-year-old with this complication.


  • Open Access

    Crohn’s Disease of the Vulva: a Case Report

    by Kalliopi Kokkali, Christos Iavazzo, Efthimia Souka, Sofia Lekka, Alexandros Fotiou, Eirini Geramani, Victoria Psomiadou, George Vorgias

    Crohn’s disease is a multi-systemic chronic inflammatory disease that can affect various organs besides the gastrointestinal tract such as joints, uvea, and the skin. Vulvar Crohn’s disease is a rare entity occurring with vulvar lesions that show typical Crohn’s disease granulomatous inflammation but are not contiguous with the gastrointestinal involvement. Vulvar Crohn’s disease can be easily confused with other granulomatous diseases and awareness that such involvement may precede gastrointestinal symptoms must be raised. Few cases of vulvar Crohn’s disease have been reported in the literature to date. Here, we report a case of a 43-year-old woman with a 6-month history of a vulvar lesion; the patient was diagnosed with Crohn’s disease of the large bowel just over a year ago.

  • Concurrent gynecologic surgery and panniculectomy in morbidly obese women with gynecologic cancer, a single-center experience

    by C. Iavazzo, V. Psomiadou, Alexandros Fotiou, Α. Prodromidou, A. Douligeris, S. Lekka, D. Korfias, E. Karavioti, G. Vorgias

    Purpose As the prevalence of obesity has been rising during the past decades worldwide and especially in Greece, surgeons have faced significant challenges concerning the treatment of morbidly obese women with gynecologic cancer. Panniculectomy is a safe procedure that offers better visualization of pelvic anatomy and prevention of major complications in these women. Methods Aim of this study is to describe a single-center experience of surgical treatment of morbidly obese women with gynecologic cancer and concurrent panniculectomy. We, also, review the literature for articles that report concurrent gynecologic surgery and panniculectomy, to summarize the complications that were encountered. Results From 2015 to 2018, 38 obese women were treated with concurrent panniculectomy at the time of gynecologic surgery for cancer in a single institution. Median age was 55.62 years old, median BMI 43.79 kg/m2, median blood loss 243.75 ml and median operative time approximately 200 min. Twenty-nine patients had endometrial cancer, one patient had concurrent endometrial cancer and fallopian tube cancer, six patients had borderline ovarian cancer, and two had adult granulosa ovarian tumour. Intraoperative and postoperative complications were documented. Five patients suffered from wound infection and were treated with antibiotics and one patient died after wound infection, wound dehiscence, and renal failure. Conclusion For selected obese patients, concurrent panniculectomy with surgical treatment of gynecological cancer is a safe and efficient procedure.


  • Safety and efficacy of synchronous panniculectomy and endometrial cancer surgery in obese patients: a systematic review of the literature and meta-analysis of postoperative complications

    by Anastasia Prodromidou, Christos Iavazzo, Victoria Psomiadou, Athanasios Douligeris, Nikolaos Machairas, Anna Paspala, Konstantinos Bakogiannis, George Vorgias

    Panniculectomy combined with gynaecological surgery constitutes an alternative approach for endometrial cancer (EC) in obese patients. The present study aimed to assess the current knowledge concerning the safety and efficacy of combining panniculectomy in surgical management of EC. Four electronic databases were systematically searched for articles published up to May 2019. A total of five studies, of which two were noncomparative and three comparative, were included. Meta-analysis of complications among panniculectomy and conventional laparotomy group revealed no difference in either intra- or post-operative complication rates. Moreover, no difference was reported in surgical site complications (p=0.59), while wound breakdown rates were significantly elevated in the laparotomy group (p=0.02). Panniculectomy combined surgery for the management of EC appears to be a safe procedure and results in comparable outcomes compared with conventional laparotomy with regard to complications and improved wound breakdown rates.


  • Open Access

    Primary Peritoneal Serous Carcinoma Detected by Abnormal Cervical Smear: a Case Report

    by Nikolaos Blontzos, Christos Iavazzo, Eirini Giovannopoulou, George Galanopoulos, Victoria Psomiadou, George Vorgias

    Primary peritoneal serous carcinoma (PPSC) is a rare malignancy, the clinical characteristics of which resemble ovarian serous carcinoma. We present a rare case of PPSC detected by an abnormal cervical smear, the first one with an absence of ovarian tissue at the time of the initial diagnosis. A 59-year-old asymptomatic woman presented with glandular atypia on routine Papanicolaou smear. Endocervical and endometrial curettage showed an adenocarcinoma with focal squamous differentiation and uncertain further classification. The patient had a past surgical history of bilateral salpingoophorectomy due to endometriosis. Abdominal MRI depicted omental multinodularity, great amount of ascites and possible endometrial tumor. The patient underwent total hysterectomy, omentectomy and biopsies of implants on Douglass pouch. Surgical and histological findings were consistent with primary peritoneal serous carcinoma. Abnormal pap smear could rarely be suggestive of extrauterine malignancies, such as peritoneal cancer.

  • Recurrence of Bartholin gland mucinous adenocarcinoma managed with posterior exenteration: a case report

    by Nikolaos Blontzos, Christos Iavazzo, Eirini Giovannopoulou, Natasa Novkovic, Victoria Psomiadou, George Vorgias

    (2019). Recurrence of Bartholin gland mucinous adenocarcinoma managed with posterior exenteration: a case report. Journal of Obstetrics and Gynaecology. Ahead of Print.


  • Primary peritoneal serous papillary carcinoma: a case series

    by Nikolaos Blontzos, Evangelos Vafias, George Vorgias, Nikolaos Kalinoglou, Christos Iavazzo

    To present the clinical and laboratory characteristics, as well as the management, of patients with primary peritoneal serous papillary carcinoma (PPSPC).


  • Is fertility sparing surgery a treatment option for young patients with yolk sac tumor?

    by Christos Iavazzo, George Vorgias, Paraskevi E. Iavazzo, Evelyn E. Minis, Ioannis D. Gkegkes

    Yolk sac tumor (YST) is the third most frequent ovarian germ cell type ovarian tumor. YST occurs primarily in young girls and in women at reproductive age and thus, the preservation of fertility is considered to be a crucial option if possible for these patients. Compared to previous years, the use of innovative chemotherapeutic regimens in the treatment of YSTs improved significantly the prognosis and outcomes of this rare type of neoplasia. As YSTs are chemosensitive, this fact favors fertility sparing surgical approach and less aggressive type of operations. We present a narrative review of the multispecialty fertility sparing surgical and medical approach of women with YST.